ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 639

Association Between Insomnia and EULAR Sjögren’s Syndrome Patient-Reported Index in Korean Patients with Primary Sjögren’s Syndrome

Jaehyung Hur1, Sang Wan Chung1, You Jung Ha2, Eun Ha Kang3, Yeong Wook Song4 and Yun Jong Lee5, 1Division of Rheumatology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam-si, South Korea, 2Division of Rheumatology, Department of Internal Medicine,Seoul National University Bundang Hospital, Seongnam, South Korea, 3Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam-si, South Korea, 4Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea, 5Internal Medicine, Seoul National University Bundang Hospital, Seongnam-si, South Korea

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: patient-reported outcome measures and sleep disorders, Sjogren's syndrome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Sjögren's Syndrome Poster I: Clinical Insights into Sjögren's Syndrome

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: EULAR Sjögren’s
syndrome Patient-Reported Index (ESSPRI) is an index to evaluate symptom
severity and recommended as an efficacy measure for clinical trials in primary Sjögren’s
syndrome (pSS) patients. The prevalence of sleep disturbance has reportedly
increased in pSS and sleep disturbance could affect pSS symptom severity.
However, the association between insomnia and ESSPRI in pSS has not been
reported.

Methods: Forty-three pSS
patients, who fulfilled the American-European Consensus Group (AECG) criteria,
consecutively were enrolled. The patients completed questionnaires on quality
of life (EQ5D), ESSPRI, insomnia (Insomnia Severity Index, ISI), sleep quality
(Pittsburgh Sleep Quality index, PSQI), fatigue (Fatigue Severity Score, FSS), and
depression (Korean Beck Depression Inventory, KBDI). Additionally, they were
evaluated by 100 mm-VAS scale for patient global assessment (PGA), oral or eye
dryness, eyeball pain, and anxiety. Data were also collected on demographic,
clinical, and laboratory variables.

Results: Among 43 pSS
patients, 10 (23.3%) had clinical insomnia (ISI>14) and 24 (55.8%) had no sleep
disturbance (ISI<8). Patients with clinical insomnia had significantly higher
ESSPRI (p=0.005), scores for FSS and KBDI (both p<0.01), and
VAS levels for dry eye, eyeball pain, anxiety, and PGA (all p<0.05)
than those without clinical insomnia. Furthermore, they had significantly lower
EQ5D score (p=0.005). ISI was significantly correlated with ESSPRI,
scores of EQ5D, FSS, and KBDI, and VAS levels of oral or eye dryness, nocturnal
xerostomia, eyeball pain, anxiety, and PGA (all p<0.05). The
distribution of ISI was significantly different according to tertiles of ESSPRI
(p<0.05, Figure 1). When high levels were defined by the upper
tertile of each continuous variables or according to the cuff off points for
ISI, KBDI, and FSS, a logistic regression analysis showed that high ESSPRI was significantly
associated with high PGA (p<0.01, OR 10.3) and clinical insomnia (p<0.05,
OR 12.5, Table 1).

Conclusion: Our results suggest
that clinical insomnia is able to independently affect ESSPRI levels and insomnia
symptom might be a target to improve ESSPRI levels in pSS patients.

Table 1. Logistic regression analysis of the association of between high ESSPRI (defined as the highest tertile) and clinical insomnia

 

Beta

Odds ratio

95% CI

P value

High PGA* for pSS

2.330

10.28

1.88 – 56.16

0.007

Clinical insomnia

2.522

12.45

1.72 – 89.94

0.012

*, high PGA was defined as the highest tertile.

Figure
1. The association between Insomnia Severity Index (ISI) and ESSPRI. (A) ISI
scores increased according to tertiles of ESSPRI in pSS patients. P value was
calculated by Kruskal-Wallis test. (B) Scatter plot showed a positive
correlation between ESSPRI and ISI in pSS patients. P value was calculated by
Spearman’s correlation.

 


Disclosure: J. Hur, None; S. W. Chung, None; Y. J. Ha, None; E. H. Kang, None; Y. W. Song, None; Y. J. Lee, None.

To cite this abstract in AMA style:

Hur J, Chung SW, Ha YJ, Kang EH, Song YW, Lee YJ. Association Between Insomnia and EULAR Sjögren’s Syndrome Patient-Reported Index in Korean Patients with Primary Sjögren’s Syndrome [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/association-between-insomnia-and-eular-sjogrens-syndrome-patient-reported-index-in-korean-patients-with-primary-sjogrens-syndrome/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/association-between-insomnia-and-eular-sjogrens-syndrome-patient-reported-index-in-korean-patients-with-primary-sjogrens-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology